{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:19:19Z","timestamp":1771273159806,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2020JJ5926"],"award-info":[{"award-number":["2020JJ5926"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771206"],"award-info":[{"award-number":["81771206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873733"],"award-info":[{"award-number":["81873733"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001195"],"award-info":[{"award-number":["82001195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171236"],"award-info":[{"award-number":["82171236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.brainres.2022.148095","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T01:26:25Z","timestamp":1663550785000},"page":"148095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Botulinum toxin type A counteracts neuropathic pain by countering the increase of GlyT2 expression in the spinal cord of CCI rats"],"prefix":"10.1016","volume":"1796","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuofeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangju","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qulian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangyuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainres.2022.148095_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lfs.2006.08.011","article-title":"Analgesic action of nicotine on tibial nerve transection (TNT)-induced mechanical allodynia through enhancement of the glycinergic inhibitory system in spinal cord","volume":"80","author":"Abdin","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2022.148095_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnsyn.2016.00007","article-title":"SNAP-25, a Known Presynaptic Protein with Emerging Postsynaptic Functions","volume":"8","author":"Antonucci","year":"2016","journal-title":"Front Synaptic Neurosci."},{"issue":"1-3","key":"10.1016\/j.brainres.2022.148095_b0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2003.08.074","article-title":"Structure, function and regulation of glycine neurotransporters","volume":"479","author":"Arag\u00f3n","year":"2003","journal-title":"Eur J Pharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2022.148095_b0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00702-004-0265-1","article-title":"Botulinum toxin type A in experimental neuropathic pain","volume":"112","author":"Bach-Rojecky","year":"2005","journal-title":"J Neural Transm (Vienna)."},{"key":"10.1016\/j.brainres.2022.148095_b0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ALN.0000000000000203","article-title":"Long-term application of glycine transporter inhibitors acts antineuropathic and modulates spinal N-methyl-D-aspartate receptor subunit NR-1 expression in rats","volume":"121","author":"Barthel","year":"2014","journal-title":"Anesthesiology."},{"key":"10.1016\/j.brainres.2022.148095_b0030","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1046\/j.1460-9568.1999.00778.x","article-title":"Redistribution of presynaptic proteins during alpha-latrotoxin-induced release of neurotransmitter and membrane retrieval at the frog neuromuscular junction","volume":"11","author":"Boudier","year":"1999","journal-title":"Eur J Neurosci."},{"key":"10.1016\/j.brainres.2022.148095_b0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1113\/jphysiol.2004.068858","article-title":"Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord","volume":"559","author":"Brada\u00efa","year":"2004","journal-title":"J Physiol."},{"issue":"2","key":"10.1016\/j.brainres.2022.148095_b0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S1740925X07000695","article-title":"Gliosis alters expression and uptake of spinal glial amino acid transporters in a mouse neuropathic pain model","volume":"3","author":"Cavaliere","year":"2007","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.brainres.2022.148095_b0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain."},{"key":"10.1016\/j.brainres.2022.148095_b0050","doi-asserted-by":"crossref","unstructured":"Durham, P.L., Cady, R., Cady, R., 2004. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache. 44, 35-42; discussion 42-3.","DOI":"10.1111\/j.1526-4610.2004.04007.x"},{"issue":"1-3","key":"10.1016\/j.brainres.2022.148095_b0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2009.06.047","article-title":"Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models","volume":"617","author":"Favre-Guilmard","year":"2009","journal-title":"Eur J Pharmacol."},{"key":"10.1016\/j.brainres.2022.148095_b0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-5793(00)01297-7","article-title":"Characterization of the interactions between the glycine transporters GLYT1 and GLYT2 and the SNARE protein syntaxin 1A","volume":"470","author":"Geerlings","year":"2000","journal-title":"FEBS Lett."},{"issue":"20","key":"10.1016\/j.brainres.2022.148095_b0065","doi-asserted-by":"crossref","first-page":"17584","DOI":"10.1074\/jbc.M010602200","article-title":"Calcium- and syntaxin 1-mediated trafficking of the neuronal glycine transporter GLYT2","volume":"276","author":"Geerlings","year":"2001","journal-title":"J Biol Chem."},{"issue":"4","key":"10.1016\/j.brainres.2022.148095_b0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0896-6273(03)00673-1","article-title":"Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality","volume":"40","author":"Gomeza","year":"2003","journal-title":"Neuron."},{"key":"10.1016\/j.brainres.2022.148095_b0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1213\/ANE.0b013e3181c7ebbb","article-title":"The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model","volume":"110","author":"Haranishi","year":"2010","journal-title":"Anesth Analg."},{"issue":"11","key":"10.1016\/j.brainres.2022.148095_b0080","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nrd3893","article-title":"Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain","volume":"12","author":"Harvey","year":"2013","journal-title":"Nat Rev Drug Discov."},{"issue":"3","key":"10.1016\/j.brainres.2022.148095_b0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2008.09.012","article-title":"Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain","volume":"445","author":"Hermanns","year":"2008","journal-title":"Neurosci Lett."},{"issue":"4","key":"10.1016\/j.brainres.2022.148095_b0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-0102(01)00289-9","article-title":"Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin","volume":"41","author":"Ito","year":"2001","journal-title":"Neurosci Res."},{"key":"10.1016\/j.brainres.2022.148095_b0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2017.00073","article-title":"Embryonic Stem Cell-Derived Neurons Grown on Multi-Electrode Arrays as a Novel In vitro Bioassay for the Detection of Clostridium botulinum Neurotoxins","volume":"8","author":"Jenkinson","year":"2017","journal-title":"Front Pharmacol."},{"issue":"16","key":"10.1016\/j.brainres.2022.148095_b0100","doi-asserted-by":"crossref","first-page":"13476","DOI":"10.1074\/jbc.M010992200","article-title":"The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A","volume":"276","author":"Keller","year":"2001","journal-title":"J Biol Chem."},{"issue":"3","key":"10.1016\/j.brainres.2022.148095_b0105","first-page":"452","article-title":"The therapeutic potential of botulinum toxin","volume":"30","author":"Klein","year":"2004","journal-title":"Dermatol Surg."},{"issue":"5","key":"10.1016\/j.brainres.2022.148095_b0110","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/PL00000899","article-title":"The glycinergic inhibitory synapse","volume":"58","author":"Legendre","year":"2001","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.brainres.2022.148095_b0115","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1042\/bst0290742","article-title":"Regulation of glycine transporters","volume":"29","author":"Lopez-Corcuera","year":"2001","journal-title":"Biochem Soc Trans."},{"issue":"9","key":"10.1016\/j.brainres.2022.148095_b0120","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1172\/JCI70026","article-title":"A feed-forward spinal cord glycinergic neural circuit gates mechanical allodynia","volume":"123","author":"Lu","year":"2013","journal-title":"J Clin Invest."},{"issue":"1","key":"10.1016\/j.brainres.2022.148095_b0125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuroscience.2010.08.067","article-title":"Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models","volume":"171","author":"Marinelli","year":"2010","journal-title":"Neuroscience."},{"key":"10.1016\/j.brainres.2022.148095_b0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tox.2015.07.003","article-title":"Botulinum neurotoxin type A: Actions beyond SNAP-25?","volume":"335","author":"Matak","year":"2015","journal-title":"Toxicology."},{"key":"10.1016\/j.brainres.2022.148095_b0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuroscience.2010.11.040","article-title":"The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord","volume":"175","author":"Mika","year":"2011","journal-title":"Neuroscience."},{"issue":"2","key":"10.1016\/j.brainres.2022.148095_b0140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.108.136267","article-title":"Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice","volume":"326","author":"Morita","year":"2008","journal-title":"J Pharmacol Exp Ther."},{"issue":"3","key":"10.1016\/j.brainres.2022.148095_b0145","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1254\/jphs.09351FP","article-title":"Blockade of glycine transporter (GlyT) 2, but not GlyT1, ameliorates dynamic and static mechanical allodynia in mice with herpetic or postherpetic pain","volume":"112","author":"Nishikawa","year":"2010","journal-title":"J Pharmacol Sci."},{"issue":"4","key":"10.1016\/j.brainres.2022.148095_b0150","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.24122","article-title":"Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction","volume":"75","author":"Paterson","year":"2014","journal-title":"Ann Neurol."},{"key":"10.1016\/j.brainres.2022.148095_b0155","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.3390\/toxins2122890","article-title":"Botulinum neurotoxin for pain management: insights from animal models","volume":"2","author":"Pavone","year":"2010","journal-title":"Toxins (Basel)."},{"issue":"8","key":"10.1016\/j.brainres.2022.148095_b0160","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.wnl.0000180940.98815.74","article-title":"An open study of botulinum-A toxin treatment of trigeminal neuralgia","volume":"65","author":"Piovesan","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.brainres.2022.148095_b0165","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1471-4159.2010.06802.x","article-title":"Functional 'glial' GLYT1 glycine transporters expressed in neurons","volume":"114","author":"Raiteri","year":"2010","journal-title":"J Neurochem."},{"key":"10.1016\/j.brainres.2022.148095_b0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neulet.2015.06.026","article-title":"Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion\u2013Possible implications for neuropathic pain","volume":"600","author":"Schlosser","year":"2015","journal-title":"Neurosci Lett."},{"issue":"3","key":"10.1016\/j.brainres.2022.148095_b0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nbd.2012.07.010","article-title":"Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A","volume":"48","author":"Shimizu","year":"2012","journal-title":"Neurobiol Dis."},{"issue":"5","key":"10.1016\/j.brainres.2022.148095_b0180","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1152\/jn.1998.80.5.2608","article-title":"Development of glycinergic synaptic transmission to rat brain stem motoneurons","volume":"80","author":"Singer","year":"1998","journal-title":"J Neurophysiol."},{"issue":"1","key":"10.1016\/j.brainres.2022.148095_b0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1152\/jn.1994.72.1.169","article-title":"The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord","volume":"72","author":"Sivilotti","year":"1994","journal-title":"J Neurophysiol."},{"issue":"4","key":"10.1016\/j.brainres.2022.148095_b0190","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/glia.23120","article-title":"Astrocyte lipid metabolism is critical for synapse development and function in vivo","volume":"65","author":"van Deijk","year":"2017","journal-title":"Glia."},{"issue":"8","key":"10.1016\/j.brainres.2022.148095_b0195","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2014.05.006","article-title":"Glycine transport inhibitors for the treatment of pain","volume":"35","author":"Vandenberg","year":"2014","journal-title":"Trends Pharmacol Sci."},{"key":"10.1016\/j.brainres.2022.148095_b0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuropharm.2017.07.018","article-title":"P2X receptors up-regulate the cell-surface expression of the neuronal glycine transporter GlyT2","volume":"125","author":"Villarejo-Lopez","year":"2017","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.brainres.2022.148095_b0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuroscience.2019.10.007","article-title":"SNAP-25 Contributes to Neuropathic Pain by Regulation of VGLuT2 Expression in Rats","volume":"423","author":"Wang","year":"2019","journal-title":"Neuroscience."},{"key":"10.1016\/j.brainres.2022.148095_b0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon."},{"key":"10.1016\/j.brainres.2022.148095_b0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tox.2013.02.006","article-title":"Botulinum toxins: mechanisms of action, antinociception and clinical applications","volume":"306","author":"Wheeler","year":"2013","journal-title":"Toxicology."},{"key":"10.1016\/j.brainres.2022.148095_b0220","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroscience.2004.04.006","article-title":"Positive N-methyl-D-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo","volume":"126","author":"Whitehead","year":"2004","journal-title":"Neuroscience."},{"key":"10.1016\/j.brainres.2022.148095_b0225","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1526-4637.2011.01182.x","article-title":"Botulinum toxin decreases hyperalgesia and inhibits P2X3 receptor over-expression in sensory neurons induced by ventral root transection in rats","volume":"12","author":"Xiao","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.brainres.2022.148095_b0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-3959(89)90160-7","article-title":"Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists","volume":"37","author":"Yaksh","year":"1989","journal-title":"Pain."},{"key":"10.1016\/j.brainres.2022.148095_b0235","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1523\/JNEUROSCI.15-05-03952.1995","article-title":"Glycine transporters are differentially expressed among CNS cells","volume":"15","author":"Zafra","year":"1995","journal-title":"J Neurosci."},{"key":"10.1016\/j.brainres.2022.148095_b0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2011.12.046","article-title":"Identification of differentially expressed proteins in the spinal cord of neuropathic pain models with PKCgamma silence by proteomic analysis","volume":"1440","author":"Zou","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2022.148095_b0245","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejphar.2016.09.019","article-title":"Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain","volume":"791","author":"Zychowska","year":"2016","journal-title":"Eur J Pharmacol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899322003195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899322003195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:22:53Z","timestamp":1757787773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899322003195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":49,"alternative-id":["S0006899322003195"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2022.148095","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin type A counteracts neuropathic pain by countering the increase of GlyT2 expression in the spinal cord of CCI rats","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2022.148095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"148095"}}